期刊文献+

补体系统及其在肝损伤再生中的作用 被引量:1

Complement and liver regeneration
原文传递
导出
摘要 评述与综述 Complement system is known as highly sophisticated immune defense mechanism and effector ann in host defense against serial infectious agents, such as cellular debris, apoptotic cells and foreign intruders. For recent decades, the traditional perception of complement in immunity has been drastically challenged by accumulating evidence for novel and unexpected functions. Generally, complement is now known to be involved in metabolism, reproduction, osteogenesis, tissue regeneration and stem cell biology, etc. In this review, recent discoveries are referred to discuss the previously under-appreciated role of complement in liver regeneration induced by various pathogens. The unintegrated effect of complement on regeneration priming and pro-inflammation modulates the balance between liver regeneration and injury, which determines the pathological process.
出处 《生命科学》 CSCD 2013年第12期1153-1160,共8页 Chinese Bulletin of Life Sciences
基金 国家自然科学基金项目(30572280 308014-54) 科技部重大新药创制项目(2012ZX-09103301-018)
关键词 补体系统 肝损伤 肝再生 免疫反应 complement system liver injury liver regeneration immune response
  • 相关文献

参考文献1

二级参考文献12

  • 1Xuebin Qin,Takashi Miwa,Huseyin Aktas,Meihua Gao,Charles Lee,Yue-Ming Qian,Cynthia C. Morton,Aliakbar Shahsafaei,Wen-Chao Song,Jose A. Halperin.Genomic structure, functional comparison, and tissue distribution of mouse Cd59a and Cd59b[J].Mammalian Genome.2001(8)
  • 2Karen K. Maves,John M. Weiler.Properdin: Approaching four decades of research[J].Immunologic Research.1993(3)
  • 3Whaley K.Measurement of complement activation in clinical practice[].Complement and Inflammation.1989
  • 4Steinberg JB,,Kapelanski DP,Olson JD,Weiler JM.Cytokine and complement levels in patients undergoing cardiopulmonary bypass[].Journal of Thoracic and Cardiovascular Surgery.1993
  • 5Benacerraf B,,Sebestyen MM,Schlossman S.A quantitative study of the kinetics of blood clearance of P32-labelled Escherichia coli and Staphylococci by the reticuloendothelial system[].The Journal of Experimental Medicine.1959
  • 6Qin X,Goldfine A,Krumrei N, et al.Glycation inactivation of the complement regulatory protein CD59: a possible role in the pathogenesis of the vascular complications of human diabetes[].Diabetes.2004
  • 7Pham BN,Mosnier JF,Durand F, et al.Immunostaining for membrane attack complex of complement is related to cell necrosis in fulminant and acute hepatitis[].Gastroenterology.1995
  • 8Strey CW,Markiewski M,Mastellos D, et al.The proinflammatory mediators C3a and C5a are essential for liver regeneration[].The Journal of Experimental Medicine.2003
  • 9Walport MJ.ComplementFirst of two parts[].The New England Journal of Medicine.2001
  • 10Walport MJ.ComplementSecond of two parts[].The New England Journal of Medicine.2001

共引文献19

同被引文献11

  • 1Bugdaci MS’Karaca C, Alkim C, et al. Serum complement C4 inchronic hepatitis C: correlation with histopathologic findings and diseaseactivity. Turk J Gastroenterol, 2012, 23(1): 33-37.
  • 2Banerjee A,Mazumdar B, Meyer K, et al. Transcriptional repressionof C4 complement by hepatitis, C vims proteins. J Virol, 2011,85(9):4157-4166.
  • 3Mazumdar B,Kim H, Meyer K, et al. Hepatitis C virus proteins inhibitC3 complement production. J Virol, 2012, 86(4): 2221-2228.
  • 4Zhang J, Hu W, Xing W, et al. The protective role of CD59 andpathogenic role of complement in hepatic ischemia and reperfusioninjury. AmJ Pathol,2011,179(6):2876-2884.
  • 5Amet T, Ghabril M, Chalasani N, et al. CD59 incorporationprotects hepatitis C virus against complement—mediated destruction.Hepatology,2012,55(2): 354-363.
  • 6ML.Alves Pedroso, ABW.Boldt, L.Pereira—Ferrari, et al. Mannan—binding lectin MBL2 gene polymorphism in chronic hepatitis C:association with the severity of liver fibrosis and response to interferontherapy. Clinical and Experimental Immunology, 2008,152(2): 258-264.
  • 7Filho RM, Carmo RF, Catsman C, et al. High frequency of variantalleles of the mannose—binding lectin 2 (MBL2) gene are associatedwith patients infected by hepatitis B virus. Viral Immunol, 2010, 23(4):449-453.
  • 8Lin Kl, He S2, He LI, et. al. Complement component 3 is a prognosticfactor of nonsmall cell lung cancer. Mol Med Rep, 2014,10(2):811-817.
  • 9张占卿,陆伟,王雁冰,饶敏,冯洁,沈芳,冯艳玲.血清补体C3和C4对慢性乙型肝炎患者肝组织病理状态的判断价值[J].世界华人消化杂志,2011,19(17):1791-1795. 被引量:4
  • 10邱国华,高媛娇,申戈,路遥,张璐,王琳,李明慧,谢尧.肝病患者血清补体C3检测的临床意义[J].中华实验和临床感染病杂志(电子版),2012,6(2):32-35. 被引量:5

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部